VivoSeq
Other

Tobacco Cessation

0

Pipeline Programs

5

Active Trials

0

Companies Involved

Tobacco Cessation is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

14

clinical trials

Completed9 · 64%
Recruiting3 · 21%
Active, not recruiting1 · 7%
Enrolling by invitation1 · 7%

Trial Activity

14 trials

Oral Cannabidiol for Tobacco Cessation
Recruiting·JJohns Hopkins University·Phase 1·NCT05445804·50 enrolled
Mobile Contingency Management for Marijuana and Tobacco Cessation
Completed··N/A·NCT02869451·7 enrolled
St. John's Wort for Tobacco Cessation
Completed·MMayo Clinic·Phase 2·NCT00405912·118 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)